Search Results - "Finch, R G"

Refine Results
  1. 1

    Safety and efficacy of glycopeptide antibiotics by Finch, R. G., Eliopoulos, G. M.

    Published in Journal of antimicrobial chemotherapy (01-03-2005)
    “…It would be difficult to envision the practice of infectious diseases over the past 20 years without the availability of the glycopeptide antibiotics. The two…”
    Get full text
    Journal Article
  2. 2

    Hepatitis C virus infection by Thomson, B.J., Finch, R.G.

    Published in Clinical microbiology and infection (01-02-2005)
    “…Hepatitis C virus (HCV) infection is a major public health problem. Up to 3% of the world's population is infected with HCV, and at least 200 000 adults in the…”
    Get full text
    Journal Article
  3. 3

    Antibiotic resistance by FINCH, R. G

    Published in Journal of antimicrobial chemotherapy (01-08-1998)
    “…Antibiotic resistance is a major factor that drives change in the pattern of antibiotic prescribing and is the most important stimulus to the development of…”
    Get full text
    Journal Article
  4. 4

    Ozone inactivation of Cryptosporidium parvum in demand-free phosphate buffer determined by in vitro excystation and animal infectivity by FINCH, G. R, BLACK, E. K, GYÜREK, L, BELOSEVIC, M

    Published in Applied and Environmental Microbiology (01-12-1993)
    “…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Modeling Water Treatment Chemical Disinfection Kinetics by Gyürék, Lyndon L, Finch, Gordon R

    “…Various empirical and probabilistic kinetic inactivation models that can be used to assist in the design and analysis of potable water disinfection systems…”
    Get full text
    Journal Article
  6. 6

    A critical assessment of published guidelines and other decision‐support systems for the antibiotic treatment of community‐acquired respiratory tract infections by Finch, R.G., Low, D.E.

    Published in Clinical microbiology and infection (01-01-2002)
    “…Guidelines are an important means by which professional associations and governments have sought to improve the quality and cost‐effectiveness of disease…”
    Get full text
    Journal Article
  7. 7

    Practical considerations and guidelines for the management of community-acquired pneumonia by FINCH, R. G, WOODHEAD, M. A

    Published in Drugs (New York, N.Y.) (1998)
    “…Community-acquired pneumonia (CAP) is a common condition which has a significant mortality. The management of a patient with CAP is centred around assessment…”
    Get full text
    Journal Article
  8. 8

    Conservative management of osteomyelitis in the feet of diabetic patients by Venkatesan, P., Lawn, S., Macfarlane, R.M., Fletcher, E.M., Finch, R.G., Jeffcoate, W.J.

    Published in Diabetic medicine (01-06-1997)
    “…Experience of conservative management of osteomyelitis in a specialized, multidisciplinary, diabetic foot clinic was reviewed. The records of all patients…”
    Get full text
    Journal Article
  9. 9

    Immunomodulating Activity of Rifampicin by Ziglam, H.M., Daniels, I., Finch, R.G.

    Published in Journal of chemotherapy (Florence) (01-08-2004)
    “…It has been shown that some antibiotics can modify cytokine production. We have examined the effect of rifampicin on secretion of interleukin-1beta (IL-1β),…”
    Get full text
    Journal Article
  10. 10

    A hospital study of community acquired pneumonia in the elderly by Venkatesan, P, Gladman, J, Macfarlane, J T, Barer, D, Berman, P, Kinnear, W, Finch, R G

    Published in Thorax (01-04-1990)
    “…Studies on community acquired pneumonia in the United States in patients over the age of 65 years have shown that Gram negative bacilli account for an…”
    Get full text
    Journal Article
  11. 11

    Medical decompression of vertebral hydatidosis by LAM, K. S, FARAJ, A, MULHOLLAND, R. C, FINCH, R. G

    Published in Spine (Philadelphia, Pa. 1976) (01-09-1997)
    “…A case report from one of the longest follow-up studies of survivors with spinal hydatid disease. This patient was treated with a combination of albendazole…”
    Get full text
    Journal Article
  12. 12

    Introduction: standards of antibacterial performance by Finch, R.G.

    Published in Clinical microbiology and infection (01-04-2004)
    “…The development and clinical use of antimicrobial agents continue to evolve in line with new science, understanding and needs. While antimicrobial resistance…”
    Get full text
    Journal Article
  13. 13

    Comparison of antibody and cytokine responses to primary Giardia muris infection in H-2 congenic strains of mice by VENKATESAN, P, FINCH, R. G, WAKELIN, D

    Published in Infection and Immunity (01-11-1996)
    “…Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  14. 14

    Design of clinical trials in sepsis : problems and pitfalls by FINCH, R. G

    “…The pathophysiology of sepsis has been studied intensively in recent years and a variety of opportunities for therapeutic intervention have been identified. A…”
    Get full text
    Conference Proceeding Journal Article
  15. 15

    Comparison of Giardia lamblia and Giardia muris cyst inactivation by ozone by Finch, G R, Black, E K, Labatiuk, C W, Gyürék, L, Belosevic, M

    Published in Applied and Environmental Microbiology (01-11-1993)
    “…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Modeling Chlorine Inactivation Requirements of Cryptosporidium parvum Oocysts by Gyürék, L. L, Finch, G. R, Belosevic, M

    “…Chlorine and monochloramine inactivation of Cryptosporidium parvum oocysts was studied using bench-scale experiments in 0.05-M phosphate buffer at pH 6 and 8…”
    Get full text
    Journal Article
  17. 17

    Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice by FINCH, G. R, DANIELS, C. W, BLACK, E. K, SCHAEFER, F. W, BELOSEVIC, M

    Published in Applied and Environmental Microbiology (01-11-1993)
    “…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Comparative inactivation of poliovirus type 3 and MS2 coliphage in demand-free phosphate buffer by using ozone by FINCH, G. R, FAIRBAIRN, N

    Published in Applied and Environmental Microbiology (01-11-1991)
    “…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Limitations of presently available glycopeptides in the treatment of Gram-positive infection by Ziglam, H.M., Finch, R.G.

    Published in Clinical microbiology and infection (01-01-2001)
    “…The glycopeptide antibacterial drugs vancomycin and teicoplanin are widely used in hospitals for therapy of severe or multiresistant Gram-positive infections,…”
    Get full text
    Journal Article
  20. 20

    Nucleic acid stains as indicators of Cryptosporidium parvum oocyst viability by Belosevic, M., Guy, R.A., Taghi-Kilani, R., Neumann, N.F., Gyürék, L.L., Liyanage, L.R.J., Millard, P.J., Finch, G.R.

    Published in International journal for parasitology (01-07-1997)
    “…We developed nucleic acid dye staining methodology for untreated, heat-treated and chemically inactivated C. parvum oocysts. The nucleic acid staining was…”
    Get full text
    Journal Article